Orthocell Limited (ASX:OCC)
0.5250
-0.0750 (-12.50%)
Oct 22, 2026, 4:10 PM AEDT
Orthocell Earnings Call Transcripts
Fiscal Year 2027
-
Remplir U.S. sales rose 21% QoQ and units 25%, while distributor coverage reached 70% of the population. AUD 39 million in cash supports commercialization and capacity expansion; management expects material growth in coming quarters.